Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |